FPCG
BSX icon

Fort Pitt Capital Group’s Boston Scientific BSX Stock Holding History

Fort Pitt Capital Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-434
Closed -$16K – 163
2020
Q4 		$16K Buy
+434
New +$15.6K ﹤0.01% 261

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Fort Pitt Capital Group's BSX Position: Q1 2021 in Review

Fort Pitt Capital Group sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 434 shares — an estimated $16K sold.

Fort Pitt Capital Group first reported a position in BSX in Q4 2020 and held it in 1 quarter. The position peaked at $16K in Q4 2020. 832 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Fort Pitt Capital Group reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Fort Pitt Capital Group sold 434 Boston Scientific shares in Q1 2021, an estimated $16K.
  • Fort Pitt Capital Group first reported a position in Boston Scientific in Q4 2020 and held it in 1 quarter.
  • Fort Pitt Capital Group's Boston Scientific position peaked at $16K in Q4 2020.
  • 832 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Fort Pitt Capital Group's 13F filing for Q1 2021, filed 16 Apr 2021.